Literature DB >> 20443870

Alterations in hematopoietic microenvironment in patients with aplastic anemia.

Irina N Shipounova1, Tatiana V Petrova, Daria A Svinareva, Kira S Momotuk, Elena A Mikhailova, Nina I Drize.   

Abstract

Mechanisms of hematopoietic failure in patients with aplastic anemia (AA) are obscure. We investigate alterations in the hematopoietic microenvironment in AA patients. We present the results of studying mesenchymal stromal cells (MSC), fibroblastic colony-forming units (CFU-F), and adherent cell layers (ACL) of long-term bone marrow cultures (LTBMC) from bone marrow (BM) samples of AA patients. MSC of AA patients proliferated longer than those of donors. In half of the patients' MSC cultures, adipogenesis was impaired. Osteogenic differentiation was not achieved in 36% of AA MSC. CFU-F formed enlarged colonies, and their concentration in the BM of AA patients was significantly increased. Our data suggest that the physiological activation of the stromal microenvironment is characteristic of AA. We detected a decrease in the expression of the angiopoetin-1 (ANG-1) and vascular cell adhesion molecule-1 (VCAM-1) genes, together with an increase in the expression of vascular endothelial growth factor (VEGF) in ACL of AA patients. This indicates abnormal regulatory patterns in both osteoblastic and vascular contexts. Addition of AA patients' serum to donors' LTBMC for 3 weeks induced similar gene expression alterations. The addition of parathyroid hormone (PTH) resulted in the expression levels of analyzed genes returning to normal, in both AA LTBMC and donor cultures treated with AA serum. The physiologic status of the BM stromal microenvironment (MSC, CFU-F, and ACL of LTBMC) of AA patients was altered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20443870      PMCID: PMC5350781          DOI: 10.1111/j.1752-8062.2008.00074.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  43 in total

1.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).

Authors:  Hongwei Cheng; Wei Jiang; Frank M Phillips; Rex C Haydon; Ying Peng; Lan Zhou; Hue H Luu; Naili An; Benjamin Breyer; Pantila Vanichakarn; Jan Paul Szatkowski; Jae Yoon Park; Tong-Chuan He
Journal:  J Bone Joint Surg Am       Date:  2003-08       Impact factor: 5.284

2.  Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia.

Authors:  Hiroyuki Takamatsu; Xingmin Feng; Tatsuya Chuhjo; Xuzhang Lu; Chiharu Sugimori; Katsuya Okawa; Miyuki Yamamoto; Shoichi Iseki; Shinji Nakao
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

3.  [Impaired expression of genes regulating homeostasis of stem hemopoietic cells in stromal cells of patients with aplastic anemia].

Authors:  T V Petrova; I N Nifontova; D A Svinareva; M A Vinogradova; E A Mikhaĭlova; N I Drize
Journal:  Ter Arkh       Date:  2008       Impact factor: 0.467

Review 4.  Stromal stem cells: marrow-derived osteogenic precursors.

Authors:  M Owen; A J Friedenstein
Journal:  Ciba Found Symp       Date:  1988

Review 5.  VEGF function in vascular pathogenesis.

Authors:  Yin-Shan Ng; Dominik Krilleke; David T Shima
Journal:  Exp Cell Res       Date:  2005-12-05       Impact factor: 3.905

6.  A cost-effective method for the automatic quantitative analysis of fibroblastic colony-forming units.

Authors:  K Dobson; L Reading; A Scutt
Journal:  Calcif Tissue Int       Date:  1999-08       Impact factor: 4.333

7.  Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.

Authors:  Rosimeire A Roela; Dirce M Carraro; Helena P Brentani; Jane H L Kaiano; Daniel F Simão; Roberto Guarnieiro; Luiz Fernando Lopes; Radovan Borojevic; M Mitzi Brentani
Journal:  Leuk Res       Date:  2006-11-07       Impact factor: 3.156

8.  Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia.

Authors:  J P Maciejewski; C Selleri; T Sato; S Anderson; N S Young
Journal:  Br J Haematol       Date:  1995-09       Impact factor: 6.998

9.  Functional changes in marrow stromal cells in aplastic anaemia.

Authors:  T Hotta; T Kato; H Maeda; H Yamao; H Yamada; H Saito
Journal:  Acta Haematol       Date:  1985       Impact factor: 2.195

10.  Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure.

Authors:  J P Maciejewski; S Anderson; P Katevas; N S Young
Journal:  Br J Haematol       Date:  1994-06       Impact factor: 6.998

View more
  21 in total

1.  Expression of IL-27, Th1 and Th17 in patients with aplastic anemia.

Authors:  Hui-zhen Du; Qian Wang; Jian Ji; Bao-ming Shen; Shao-chun Wei; Li-juan Liu; Juan Ding; Dao-xin Ma; Wen Wang; Jun Peng; Ming Hou
Journal:  J Clin Immunol       Date:  2012-09-30       Impact factor: 8.317

2.  Evaluation of Bone Marrow Microvessel Density in Patients with Aplastic Anemia.

Authors:  Venkatesan Somasundaram; Manvir Singh Tevatia; Abhishek Purohit; Ankur Ahuja; Manoranjan Mahapatra; Seema Tyagi; Haraprasad Pati; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2016-07-19       Impact factor: 0.900

3.  Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.

Authors:  Liangliang Wu; Wenjian Mo; Yuping Zhang; Ming Zhou; Yumiao Li; Ruiqing Zhou; Shiling Xu; Shiyi Pan; Hui Deng; Ping Mao; Shunqing Wang
Journal:  Int J Hematol       Date:  2017-03-16       Impact factor: 2.490

4.  Bone Marrow Multipotent Mesenchymal Stromal Cells from Patients with Aplastic Anemia Retain Their Ability to Support Hematopoietic Precursors despite Pronounced Changes in Gene Expression.

Authors:  A I Dorofeeva; I N Shipunova; N I Drize; A V Luchkin; A V Abramova; Z T Fidarova; V N Dvirnyk; I V Gal'tseva; E A Mikhailova; E N Parovichnikova
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.804

Review 5.  Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate.

Authors:  Cristina Sobacchi; Eleonora Palagano; Anna Villa; Ciro Menale
Journal:  Front Bioeng Biotechnol       Date:  2017-05-17

6.  Effects of sodium copper chlorophyllin on mesenchymal stem cell function in aplastic anemia mice.

Authors:  Li-Ming Yin; Hui-Fang Jiang; Xiao Wang; Xu-Dai Qian; Rui-Lan Gao; Xiao-Jie Lin; Xiao-Hong Chen; Ling-Cong Wang
Journal:  Chin J Integr Med       Date:  2012-09-21       Impact factor: 1.978

7.  Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.

Authors:  Clara Bueno; Mar Roldan; Eduardo Anguita; Damia Romero-Moya; Beatriz Martín-Antonio; Michael Rosu-Myles; Consuelo del Cañizo; Francisco Campos; Regina García; Maite Gómez-Casares; Jose Luis Fuster; Manuel Jurado; Mario Delgado; Pablo Menendez
Journal:  Haematologica       Date:  2014-04-11       Impact factor: 9.941

8.  Human Acquired Aplastic Anemia Patients' Bone-Marrow-Derived Mesenchymal Stem Cells Are Not Influenced by Hematopoietic Compartment and Maintain Stemness and Immune Properties.

Authors:  Vandana Sharma; Sonali Rawat; Suchi Gupta; Sweta Tamta; Rinkey Sharma; Tulika Seth; Sujata Mohanty
Journal:  Anemia       Date:  2021-04-29

9.  Reconstruction of hematopoietic inductive microenvironment after transplantation of VCAM-1-modified human umbilical cord blood stromal cells.

Authors:  Yao Liu; Xing-hua Chen; Ying-jian Si; Zhong-jun Li; Lei Gao; Li Gao; Cheng Zhang; Xi Zhang
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

10.  Ginsenoside Rg1 can restore hematopoietic function by inhibiting Bax translocation-mediated mitochondrial apoptosis in aplastic anemia.

Authors:  Huiqin Cao; Wei Wei; Ruirong Xu; Xing Cui
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.